Efficacy of D-alanine intake in patients with chronic kidney disease; a randomized controlled pilot trial - D-alanine CKD pilot trial

Oshima Megumi0 个研究点目标入组 24 人开始时间: 2024年2月6日最近更新: 2024年5月27日

适应症

试验速览

暂无简介。

•Patients who meet all of the following criteria are included.
•1) Patients who aged 20 years or older at the time of obtaining the informed consent.
•2) Sustained urine protein to creatinine ratio higher than 0.5 g/gCr or urine albumin to creatine ratio higher than 300 mg/gCr for more than two consecutive visits
•3) The written consent can be obtained after informed consent for participation in the study.

•Patients who meet any of the following criteria are excluded.
•1) Patients undergoing dialysis therapy
•2) Pregnant or lactating mothers
•3) Patinets who take antimicrobials or medications for intestine disorders including lactobacillus preparations
•4) Patients who take food for specified health uses or food with functional claims that labels the improvement of the intestinal environment at the study entry
•5) Initiation of SGLT2 inhibitors within 8 weeks prior to the study entry
•6) Initiation of RAS blockers within 8 weeks prior to the study entry
•7) Participation in other clinical studies within 8 weeks prior to the study entry
•8) Not appropriate as participants

发起方

Oshima Megumi